| James Brian Olack, MD | |
|
2450 E Show Low Lake Rd, Suite 2a, Show Low, AZ 85901-7953 | |
| (928) 537-6767 | |
| (928) 537-0299 |
| Full Name | James Brian Olack |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 21 Years |
| Location | 2450 E Show Low Lake Rd, Show Low, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669686135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME103523 (Florida) | Secondary |
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 43222 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summit Healthcare Regional Medical Center | Show low, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Healthcare Medical Associates | 8729205737 | 76 |
News Archive
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
The syrupy soup of proteins, ribosomes and membranes inside a living cell is so tightly packed it may increase the structural content of proteins by as much as 25 percent, according to new research from Rice University and the University of Houston (UH).
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
› Verified 7 days ago
| Entity Name | Summit Healthcare Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144209271 PECOS PAC ID: 3779568647 Enrollment ID: O20040623001125 |
News Archive
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
The syrupy soup of proteins, ribosomes and membranes inside a living cell is so tightly packed it may increase the structural content of proteins by as much as 25 percent, according to new research from Rice University and the University of Houston (UH).
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
› Verified 7 days ago
| Entity Name | Summit Healthcare Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467878108 PECOS PAC ID: 8729205737 Enrollment ID: O20140815000931 |
News Archive
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
The syrupy soup of proteins, ribosomes and membranes inside a living cell is so tightly packed it may increase the structural content of proteins by as much as 25 percent, according to new research from Rice University and the University of Houston (UH).
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Brian Olack, MD 2450 E Show Low Lake Rd, Suite 2a, Show Low, AZ 85901-7953 Ph: (928) 537-6767 | James Brian Olack, MD 2450 E Show Low Lake Rd, Suite 2a, Show Low, AZ 85901-7953 Ph: (928) 537-6767 |
News Archive
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
The syrupy soup of proteins, ribosomes and membranes inside a living cell is so tightly packed it may increase the structural content of proteins by as much as 25 percent, according to new research from Rice University and the University of Houston (UH).
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
› Verified 7 days ago
William J Waldo, MD Surgery Medicare: Medicare Enrolled Practice Location: 2650 E Show Low Lake Rd, Suite 2, Show Low, AZ 85901 Phone: 928-537-4240 Fax: 928-537-4541 | |
Michael Edward Tieman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5171 Cub Lake Rd, Suite 280, Show Low, AZ 85901 Phone: 928-532-5463 Fax: 928-532-8474 | |
Dr. Burke Delange, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5171 Cub Lake Rd, Suite C 350, Show Low, AZ 85901 Phone: 928-537-8285 | |
Doran James Schneider, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 5171 Cub Lake Rd, Suite 390, Show Low, AZ 85901 Phone: 928-532-5463 Fax: 928-532-8474 |